サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1454122

心臓病・神経向けIVD市場：製品タイプ別、技術別、最終用途別、国別、地域別 - 産業分析、市場規模、市場シェア、予測、2024-2032年

IVD In Cardiology And Neurology Market, By Product Type, By Technology, By End-use, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日: | 発行: AnalystView Market Insights | ページ情報: 英文 300 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.70円
心臓病・神経向けIVD市場：製品タイプ別、技術別、最終用途別、国別、地域別 - 産業分析、市場規模、市場シェア、予測、2024-2032年
出版日: 2024年03月15日
発行: AnalystView Market Insights
ページ情報: 英文 300 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

レポートハイライト

心臓病・神経向けIVD市場規模は2023年に159億6,500万米ドルと評価され、2024年から2032年にかけてCAGR 9.5%で拡大

心臓病・神経向けIVD市場-市場力学

心血管疾患の有病率の増加が市場需要を促進

心血管疾患の有病率の増加は、予測期間にわたって心臓病・神経向けIVD市場を促進すると予想されます。例えば、National Institutes of Healthが発表したデータによると、インドにおけるCVDによる死亡者数は1990年の226万人から2020年には477万人に増加すると予測されています。過去数十年にわたり、インドにおける冠動脈性心疾患の有病率は、農村部では1.6％から7.4％、大都市部では1％から13.2％と、さまざまな数値が推定されています。したがって、前述の統計が市場成長の原動力となっています。

心臓病・神経向けIVD市場-主要インサイト

弊社のリサーチアナリストの分析によると、世界市場は予測期間（2024-2032年）に約9.5%のCAGRで毎年成長すると予測されています。

製品タイプ別では、試薬・消耗品セグメントが予測期間中に大きな市場シェアを獲得すると予測されています。

技術セグメンテーションに基づくと、2023年にはイムノアッセイセグメンテーションが最大の市場シェアを占めました。

最終用途セグメンテーションに基づくと、病院セグメントが予測期間中に市場をリードすると予想されます。

地域別では、北米が2023年の売上高でトップ

心臓病・神経向けIVD市場-セグメンテーション分析：

心臓病・神経向けIVDの世界市場は、製品タイプ、技術、最終用途、地域に基づいてセグメント化されます。

製品タイプに基づき、市場は機器、試薬・消耗品、ソフトウェア・サービスに分類されます。試薬・消耗品セグメントは、予測期間中に大きな市場シェアを獲得する見込みです。免疫化学実験では、蛍光タグ、洗浄バッファー、特定の抗体、タンパク質バイオマーカーを含む試薬が利用されます。PCR検査は、塩化マグネシウム、dNTPミックス、プライマーミックスなど様々な物質を用いて行われます。プライマーセットと蛍光標識ヌクレオチドは、分子診断法において主要かつ最も一般的に使用される試薬です。アボット社、ロシュ・ダイアグノスティックス社、イルミナ社が試薬の主なサプライヤーです。主要メーカーが研究開発活動を通じて革新的なバイオマーカーキットを開発したことが、同分野の成長につながっています。さらに、新規試薬の発売と商業化が市場の拡大を促進すると予想されます。

市場は技術別に分子診断、イムノアッセイ、血液学、その他に分けられます。2023年にはイムノアッセイが最大の市場シェアを占め、予測期間中も同じパターンが続くと予想されます。免疫学では、免疫系が果たす多様な役割を理解するために分子経路が研究されています。主に抗原と抗体の相互作用や作用機序の評価からなります。企業はイムノアッセイの開発と販売に注力しています。

最終用途に基づき、業界は臨床検査室、病院、その他に分けられます。病院分野は、医師が治療を進めるために診断解釈を必要とすることから、予測期間中に市場をリードすることが予想され、同分野の発展が期待されています。

心臓病・神経向けIVD市場-地理的洞察

地理的には、この市場は北米、ラテンアメリカ、欧州、アジア太平洋、中東アフリカの地域に広がっています。これらの地域は、ビジネスを展開する国によってさらに分けられます。北米は、心血管疾患や神経疾患の有病率の増加、有益な政府プログラムの拡大など、多くの変数により、予測期間中、心臓病・神経向けIVD市場をリードすると予想されます。また、革新的なバイオマーカーの研究開発に対する製品リリースや資金調達の増加も、同市場の成長に拍車をかけると予想されます。

心臓病・神経向けIVD市場-競合情勢：

市場で事業を展開する主要企業は、Quest Diagnostics Incorporated、BD、Sysmex Corporation、Siemens Healthineers AG、Thermo Fisher Scientific Inc.、Abbott、F. Hoffmann-La Roche Ltd.、Bio-Rad Laboratories, Inc.、Beckman Coulter, Inc.、Cardiol Therapeuticsです。新市場へのアクセスを得るため、市場参入企業は新製品の開発、資金調達や投資、M&A、その他の戦略的提携など、さまざまな戦略的イニシアチブを継続的に追求しています。

目次

第1章 心臓病・神経向けIVD市場概要

  • 調査範囲
  • 市場推定年数

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 心臓病・神経向けIVDの主要な市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 今後の市場動向

第4章 心臓病・神経向けIVD業界調査

  • PEST分析
  • ポーターのファイブフォース分析
  • 成長見通しのマッピング
  • 規制枠組みの分析

第5章 心臓病・神経向けIVD市場：COVID-19の影響分析

  • COVID-19以前の影響分析
  • COVID-19後の影響分析

第6章 心臓病・神経向けIVDの市場情勢

  • 心臓病・神経向けIVD市場シェア分析、2023年
  • 主要メーカー別の内訳データ
    • 既存企業の分析
    • 新興企業の分析

第7章 心臓病・神経向けIVD市場-製品タイプ別

  • 概要
    • 製品タイプ別のセグメントシェア分析
    • 機器
    • 試薬・消耗品
    • ソフトウェア・サービス

第8章 心臓病・神経向けIVD市場-技術別

  • 概要
    • 技術別のセグメントシェア分析
    • 分子診断
    • イムノアッセイ
    • 血液学
    • その他

第9章 心臓病・神経向けIVD市場-最終用途別

  • 概要
    • 最終用途別のセグメントシェア分析
    • 臨床検査室
    • 病院
    • その他

第10章 心臓病・神経向けIVD市場-地域別

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • イタリア
    • 英国
    • フランス
    • ロシア
    • オランダ
    • スウェーデン
    • ポーランド
    • その他
  • アジア太平洋（APAC）
    • 概要
    • アジア太平洋地域の主要メーカー
    • インド
    • 中国
    • 日本
    • 韓国
    • オーストラリア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東とアフリカ
    • 概要
    • 中東とアフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第11章 主要ベンダー分析-心臓病・神経向けIVD業界

  • 競合ダッシュボード
  • 企業プロファイル
    • Quest Diagnostics Incorporated
    • BD
    • Sysmex Corporation
    • Siemens Healthineers AG
    • Thermo Fisher Scientific Inc.
    • Abbott
    • F. Hoffmann-La Roche Ltd.
    • Bio-Rad Laboratories, Inc.
    • Beckman Coulter, Inc.
    • Cardiol Therapeutics

第12章 アナリストの全方位展望

図表

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE IVD IN CARDIOLOGY AND NEUROLOGY Market: Product Type Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Product Type
  • TABLE Global IVD IN CARDIOLOGY AND NEUROLOGY Market, by Product Type 2019-2032 (USD Million)
  • TABLE IVD IN CARDIOLOGY AND NEUROLOGY Market: Technology Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Technology
  • TABLE Global IVD IN CARDIOLOGY AND NEUROLOGY Market, by Technology 2019-2032 (USD Million)
  • TABLE IVD IN CARDIOLOGY AND NEUROLOGY Market: End-useSnapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by End-use
  • TABLE Global IVD IN CARDIOLOGY AND NEUROLOGY Market, by End-use2019-2032 (USD Million)
  • TABLE IVD IN CARDIOLOGY AND NEUROLOGY Market: Regional snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global IVD IN CARDIOLOGY AND NEUROLOGY Market, by Region 2019-2032 (USD Million)
  • TABLE North America IVD IN CARDIOLOGY AND NEUROLOGY Market, by Country, 2019-2032 (USD Million)
  • TABLE North America IVD IN CARDIOLOGY AND NEUROLOGY Market, by Product Type, 2019-2032 (USD Million)
  • TABLE North America IVD IN CARDIOLOGY AND NEUROLOGY Market, by Technology, 2019-2032 (USD Million)
  • TABLE North America IVD IN CARDIOLOGY AND NEUROLOGY Market, by End-use, 2019-2032 (USD Million)
  • TABLE Europe IVD IN CARDIOLOGY AND NEUROLOGY Market, by Country, 2019-2032 (USD Million)
  • TABLE Europe IVD IN CARDIOLOGY AND NEUROLOGY Market, by Product Type, 2019-2032 (USD Million)
  • TABLE Europe IVD IN CARDIOLOGY AND NEUROLOGY Market, by Technology, 2019-2032 (USD Million)
  • TABLE Europe IVD IN CARDIOLOGY AND NEUROLOGY Market, by End-use, 2019-2032 (USD Million)
  • TABLE Asia Pacific IVD IN CARDIOLOGY AND NEUROLOGY Market, by Country, 2019-2032 (USD Million)
  • TABLE Asia Pacific IVD IN CARDIOLOGY AND NEUROLOGY Market, by Product Type, 2019-2032 (USD Million)
  • TABLE Asia Pacific IVD IN CARDIOLOGY AND NEUROLOGY Market, by Technology, 2019-2032 (USD Million)
  • TABLE Asia Pacific IVD IN CARDIOLOGY AND NEUROLOGY Market, by End-use, 2019-2032 (USD Million)
  • TABLE Latin America IVD IN CARDIOLOGY AND NEUROLOGY Market, by Country, 2019-2032 (USD Million)
  • TABLE Latin America IVD IN CARDIOLOGY AND NEUROLOGY Market, by Product Type, 2019-2032 (USD Million)
  • TABLE Latin America IVD IN CARDIOLOGY AND NEUROLOGY Market, by Technology, 2019-2032 (USD Million)
  • TABLE Latin America IVD IN CARDIOLOGY AND NEUROLOGY Market, by End-use, 2019-2032 (USD Million)
  • TABLE Middle East and Africa IVD IN CARDIOLOGY AND NEUROLOGY Market, by Country, 2019-2032 (USD Million)
  • TABLE Middle East and Africa IVD IN CARDIOLOGY AND NEUROLOGY Market, by Product Type, 2019-2032 (USD Million)
  • TABLE Middle East and Africa IVD IN CARDIOLOGY AND NEUROLOGY Market, by Technology, 2019-2032 (USD Million)
  • TABLE Middle East and Africa IVD IN CARDIOLOGY AND NEUROLOGY Market, by End-use, 2019-2032 (USD Million)

List of Figures

  • FIGURE IVD IN CARDIOLOGY AND NEUROLOGY Market Segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2023
  • FIGURE Product Type segment market share analysis, 2023 & 2032
  • FIGURE Product Type segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Technology segment market share analysis, 2023 & 2032
  • FIGURE Technology segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE End-usesegment market share analysis, 2023 & 2032
  • FIGURE End-usesegment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Regional segment market share analysis, 2023 & 2032
  • FIGURE Regional segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE North America IVD IN CARDIOLOGY AND NEUROLOGY Market share and leading players, 2023
  • FIGURE Europe IVD IN CARDIOLOGY AND NEUROLOGY Market share and leading players, 2023
  • FIGURE Asia Pacific IVD IN CARDIOLOGY AND NEUROLOGY Market share and leading players, 2023
  • FIGURE Latin America IVD IN CARDIOLOGY AND NEUROLOGY Market share and leading players, 2023
  • FIGURE Middle East and Africa IVD IN CARDIOLOGY AND NEUROLOGY Market share and leading players, 2023
  • FIGURE North America market share analysis by country, 2023
  • FIGURE U.S. IVD IN CARDIOLOGY AND NEUROLOGY Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Canada IVD IN CARDIOLOGY AND NEUROLOGY Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Europe IVD IN CARDIOLOGY AND NEUROLOGY Market share analysis by country, 2023
  • FIGURE Germany IVD IN CARDIOLOGY AND NEUROLOGY Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Spain IVD IN CARDIOLOGY AND NEUROLOGY Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Italy IVD IN CARDIOLOGY AND NEUROLOGY Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE France IVD IN CARDIOLOGY AND NEUROLOGY Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE UK IVD IN CARDIOLOGY AND NEUROLOGY Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Russia IVD IN CARDIOLOGY AND NEUROLOGY Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Netherlands IVD IN CARDIOLOGY AND NEUROLOGY Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Sweden IVD IN CARDIOLOGY AND NEUROLOGY Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Poland IVD IN CARDIOLOGY AND NEUROLOGY Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of the Europe IVD IN CARDIOLOGY AND NEUROLOGY Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Asia Pacific IVD IN CARDIOLOGY AND NEUROLOGY Market share analysis by country, 2023
  • FIGURE India IVD IN CARDIOLOGY AND NEUROLOGY Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE China IVD IN CARDIOLOGY AND NEUROLOGY Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Japan IVD IN CARDIOLOGY AND NEUROLOGY Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE South Korea IVD IN CARDIOLOGY AND NEUROLOGY Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Australia IVD IN CARDIOLOGY AND NEUROLOGY Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Thailand IVD IN CARDIOLOGY AND NEUROLOGY Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Indonesia IVD IN CARDIOLOGY AND NEUROLOGY Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Phillipines IVD IN CARDIOLOGY AND NEUROLOGY Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of APAC IVD IN CARDIOLOGY AND NEUROLOGY Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Latin America IVD IN CARDIOLOGY AND NEUROLOGY Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Latin America IVD IN CARDIOLOGY AND NEUROLOGY Market share analysis by country, 2023
  • FIGURE Brazil IVD IN CARDIOLOGY AND NEUROLOGY Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Mexico IVD IN CARDIOLOGY AND NEUROLOGY Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Argentina IVD IN CARDIOLOGY AND NEUROLOGY Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Colombia IVD IN CARDIOLOGY AND NEUROLOGY Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of LATAM IVD IN CARDIOLOGY AND NEUROLOGY Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Middle East and Africa IVD IN CARDIOLOGY AND NEUROLOGY Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Middle East and Africa IVD IN CARDIOLOGY AND NEUROLOGY Market share analysis by country, 2023
  • FIGURE Saudi Arabia IVD IN CARDIOLOGY AND NEUROLOGY Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE United Arab Emirates IVD IN CARDIOLOGY AND NEUROLOGY Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Israel IVD IN CARDIOLOGY AND NEUROLOGY Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Turkey IVD IN CARDIOLOGY AND NEUROLOGY Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Algeria IVD IN CARDIOLOGY AND NEUROLOGY Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Egypt IVD IN CARDIOLOGY AND NEUROLOGY Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of MEA IVD IN CARDIOLOGY AND NEUROLOGY Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
目次
Product Code: ANV2303

REPORT HIGHLIGHT

IVD In Cardiology And Neurology Market size was valued at USD 15,965 Million in 2023, expanding at a CAGR of 9.5% from 2024 to 2032.

The term "in vitro diagnostics" (IVD) describes the use of instruments, techniques, and reagents designed for the analysis of specimens-such as blood, urine, tissue, and other bodily fluids-outside of the body to aid in the diagnosis of illnesses, ailments, or infections. These laboratory-based tests are intended to give information on a patient's health state, supporting the identification of illnesses, selection of appropriate courses of treatment, and ongoing monitoring of those illnesses.

IVD In Cardiology And Neurology Market- Market Dynamics

Growing prevalence of cardiovascular disease to propel market demand

The growing prevalence of cardiovascular disease is expected to propel the IVD In Cardiology And Neurology market over the projected period. For instance, according to the data published by National Institutes of Health, it is anticipated that the number of fatalities in India from CVD would increase from 2.26 million in 1990 to 4.77 million in 2020. Over the past few decades, estimates of the prevalence of coronary heart disease in India have varied, with figures ranging from 1.6% to 7.4% in rural areas and from 1% to 13.2% in metropolitan areas. Thus, the aforementioned stats drive the market growth.

IVD In Cardiology And Neurology Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 9.5% over the forecast period (2024-2032)

Based on product type segmentation, the Reagents & Consumables segment is expected to capture a significant market share during the forecast period

Based on the technology segmentation, the Immunoassays segment held the largest market share in 2023

Based on end-use segmentation, the hospitals segment is expected to lead the market over the projected period

Based on region, North America was the leading revenue generator in 2023

IVD In Cardiology And Neurology Market- Segmentation Analysis:

The Global IVD In Cardiology And Neurology Market is segmented based on Product Type, Technology, End-use, and Region.

Based on the product type, the market is categorized into Instruments, Reagents & Consumables and Software and Services. The Reagents & Consumables segment is expected to capture a significant market share during the forecast period. In immunochemistry experiments, reagents including fluorescent tags, washing buffers, particular antibodies, and protein biomarkers are utilized. PCR tests are carried out using a variety of substances, including magnesium chloride, dNTP mix, and primer mix. Primer sets and fluorescent-labeled nucleotides are the main and most commonly utilized reagents in molecular diagnostic procedures. Abbott, Roche Diagnostics, and Illumina, Inc. are the main suppliers of reagents. The development of innovative biomarker kits by key manufacturers through considerable R&D activities is credited with the segment's rise. Additionally, it is anticipated that the launch and commercialization of novel reagents would propel market expansion.

Based on the technology, the market is divided into Molecular Diagnostics, Immunoassays, Hematology and Others. The Immunoassays held the largest market share in 2023 and is expected to continue the same pattern during the forecast period. Molecular pathways are studied in immunology to comprehend the diverse roles that the immune system plays. It primarily consists of an evaluation of the interactions between antigens and antibodies as well as their mechanisms of action. Businesses are concentrating on the creation and marketing of immunoassays.

Based on the end-use, the industry is divided into Clinical Laboratories, Hospitals and Others. The hospitals segment is expected to lead the market over the projected period due to the fact that physicians need diagnostic interpretation to proceed with therapy, the segment is expected to develop.

IVD In Cardiology And Neurology Market- Geographical Insights

Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business. North America is expected to lead the IVD In Cardiology And Neurology market during the forecast period due to a number of variables, including the growing prevalence of cardiovascular and neurological diseases and the expansion of beneficial government programs. Growth in the market is also anticipated to be fueled by more product releases and financing for the R&D of innovative biomarkers.

IVD In Cardiology And Neurology Market- Competitive Landscape:

The key players operating in the market are Quest Diagnostics Incorporated, BD, Sysmex Corporation, Siemens Healthineers AG, Thermo Fisher Scientific Inc., Abbott, F. Hoffmann-La Roche Ltd., Bio-Rad Laboratories, Inc., Beckman Coulter, Inc. and Cardiol Therapeutics. To obtain access to new markets, market players are continuously pursuing a variety of strategic initiatives, including the creation of new products, funding and investments, mergers and acquisitions, and other strategic partnerships.

Recent Developments:

In July 2023, a collaboration between Fujirebio and Beckman Coulter, Inc. aims to improve patient access to blood-based Alzheimer disease testing. The collaboration intends to pool the business's immunoassay capabilities to provide support.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL IVD IN CARDIOLOGY AND NEUROLOGY MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Quest Diagnostics Incorporated

BD

Sysmex Corporation

Siemens Healthineers AG

Thermo Fisher Scientific Inc.

Abbott

F. Hoffmann-La Roche Ltd.

Bio-Rad Laboratories, Inc.

Beckman Coulter, Inc.

Cardiol Therapeutics

GLOBAL IVD IN CARDIOLOGY AND NEUROLOGY MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032

  • Instruments
  • Reagents & Consumables
  • Software and Services

GLOBAL IVD IN CARDIOLOGY AND NEUROLOGY MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2019 - 2032

  • Molecular Diagnostics
  • Immunoassays
  • Hematology
  • Others

GLOBAL IVD IN CARDIOLOGY AND NEUROLOGY MARKET, BY END-USE- MARKET ANALYSIS, 2019 - 2032

  • Clinical Laboratories
  • Hospitals
  • Others

GLOBAL IVD IN CARDIOLOGY AND NEUROLOGY MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1.IVD IN CARDIOLOGY AND NEUROLOGY Market Overview

  • 1.1.Study Scope
  • 1.2.Market Estimation Years

2.Executive Summary

  • 2.1.Market Snippet
    • 2.1.1.IVD IN CARDIOLOGY AND NEUROLOGY Market Snippet by Product Type
    • 2.1.2.IVD IN CARDIOLOGY AND NEUROLOGY Market Snippet by Technology
    • 2.1.3.IVD IN CARDIOLOGY AND NEUROLOGY Market Snippet by End-use
    • 2.1.4.IVD IN CARDIOLOGY AND NEUROLOGY Market Snippet by Country
    • 2.1.5.IVD IN CARDIOLOGY AND NEUROLOGY Market Snippet by Region
  • 2.2.Competitive Insights

3.IVD IN CARDIOLOGY AND NEUROLOGY Key Market Trends

  • 3.1.IVD IN CARDIOLOGY AND NEUROLOGY Market Drivers
    • 3.1.1.Impact Analysis of Market Drivers
  • 3.2.IVD IN CARDIOLOGY AND NEUROLOGY Market Restraints
    • 3.2.1.Impact Analysis of Market Restraints
  • 3.3.IVD IN CARDIOLOGY AND NEUROLOGY Market Opportunities
  • 3.4.IVD IN CARDIOLOGY AND NEUROLOGY Market Future Trends

4.IVD IN CARDIOLOGY AND NEUROLOGY Industry Study

  • 4.1.PEST Analysis
  • 4.2.Porter's Five Forces Analysis
  • 4.3.Growth Prospect Mapping
  • 4.4.Regulatory Framework Analysis

5.IVD IN CARDIOLOGY AND NEUROLOGY Market: COVID-19 Impact Analysis

  • 5.1.Pre-COVID-19 Impact Analysis
  • 5.2.Post-COVID-19 Impact Analysis
    • 5.2.1.Top Performing Segments
    • 5.2.2.Marginal Growth Segments
    • 5.2.3.Top Looser Segments
    • 5.2.4.Marginal Loss Segments

6.IVD IN CARDIOLOGY AND NEUROLOGY Market Landscape

  • 6.1.IVD IN CARDIOLOGY AND NEUROLOGY Market Share Analysis, 2023
  • 6.2.Breakdown Data, by Key Manufacturer
    • 6.2.1.Established Players' Analysis
    • 6.2.2.Emerging Players' Analysis

7.IVD IN CARDIOLOGY AND NEUROLOGY Market - By Product Type

  • 7.1.Overview
    • 7.1.1.Segment Share Analysis, By Product Type, 2023 & 2032 (%)
    • 7.1.2.Instruments
    • 7.1.3.Reagents & Consumables
    • 7.1.4.Software and Services

8.IVD IN CARDIOLOGY AND NEUROLOGY Market - By Technology

  • 8.1.Overview
    • 8.1.1.Segment Share Analysis, By Technology, 2023 & 2032 (%)
    • 8.1.2.Molecular Diagnostics
    • 8.1.3.Immunoassays
    • 8.1.4.Hematology
    • 8.1.5.Others

9.IVD IN CARDIOLOGY AND NEUROLOGY Market - By End-use

  • 9.1.Overview
    • 9.1.1.Segment Share Analysis, By End-use, 2023 & 2032 (%)
    • 9.1.2.Clinical Laboratories
    • 9.1.3.Hospitals
    • 9.1.4.Others

10.IVD IN CARDIOLOGY AND NEUROLOGY Market- By Geography

  • 10.1.Introduction
    • 10.1.1.Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 10.2.North America
    • 10.2.1.Overview
    • 10.2.2.IVD IN CARDIOLOGY AND NEUROLOGY Key Manufacturers in North America
    • 10.2.3.North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4.North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.2.5.North America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.2.6.North America Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.2.7.U.S.
      • 10.2.7.1.Overview
      • 10.2.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3.U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.2.7.4.U.S. Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.2.7.5.U.S. Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.2.8.Canada
      • 10.2.8.1.Overview
      • 10.2.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3.Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.2.8.4.Canada Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.2.8.5.Canada Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
  • 10.3.Europe
    • 10.3.1.Overview
    • 10.3.2.IVD IN CARDIOLOGY AND NEUROLOGY Key Manufacturers in Europe
    • 10.3.3.Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4.Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.3.5.Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.3.6.Europe Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.3.7.Germany
      • 10.3.7.1.Overview
      • 10.3.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3.Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.7.4.Germany Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.7.5.Germany Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.3.8.Italy
      • 10.3.8.1.Overview
      • 10.3.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3.Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.8.4.Italy Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.8.5.Italy Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.3.9.United Kingdom
      • 10.3.9.1.Overview
      • 10.3.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3.United Kingdom Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.9.4.United Kingdom Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.9.5.United Kingdom Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.3.10.France
      • 10.3.10.1.Overview
      • 10.3.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3.France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.10.4.France Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.10.5.France Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.3.11.Russia
      • 10.3.11.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.2.Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.11.3.Russia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.11.4.Russia Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.3.12.Netherlands
      • 10.3.12.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2.Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.12.3.Netherlands Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.12.4.Netherlands Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.3.13.Sweden
      • 10.3.13.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2.Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.13.3.Sweden Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.13.4.Sweden Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.3.14.Poland
      • 10.3.14.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2.Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.14.3.Poland Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.14.4.Poland Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.3.15.Rest of Europe
      • 10.3.15.1.Overview
      • 10.3.15.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3.Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.15.4.Rest of the Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.15.5.Rest of the Europe Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
  • 10.4.Asia Pacific (APAC)
    • 10.4.1.Overview
    • 10.4.2.IVD IN CARDIOLOGY AND NEUROLOGY Key Manufacturers in Asia Pacific
    • 10.4.3.Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4.Asia Pacific Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.4.5.Asia Pacific Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.4.6.Asia Pacific Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.4.7.India
      • 10.4.7.1.Overview
      • 10.4.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3.India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.7.4.India Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.7.5.India Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.4.8.China
      • 10.4.8.1.Overview
      • 10.4.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3.China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.8.4.China Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.8.5.China Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.4.9.Japan
      • 10.4.9.1.Overview
      • 10.4.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3.Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.9.4.Japan Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.9.5.Japan Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.4.10.South Korea
      • 10.4.10.1.Overview
      • 10.4.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3.South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.10.4.South Korea Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.10.5.South Korea Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.4.11.Australia
      • 10.4.11.1.Overview
      • 10.4.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3.Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.11.4.Australia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.11.5.Australia Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.4.12.Thailand
      • 10.4.12.1.Overview
      • 10.4.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3.Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.12.4.Thailand Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.12.5.Thailand Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.4.13.Indonesia
      • 10.4.13.1.Overview
      • 10.4.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3.Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.13.4.Indonesia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.13.5.Indonesia Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.4.14.Philippines
      • 10.4.14.1.Overview
      • 10.4.14.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3.Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.14.4.Philippines Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.14.5.Philippines Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.4.15.Rest of APAC
      • 10.4.15.1.Overview
      • 10.4.15.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3.Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.15.4.Rest of APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.15.5.Rest of APAC Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
  • 10.5.Latin America
    • 10.5.1.Overview
    • 10.5.2.IVD IN CARDIOLOGY AND NEUROLOGY Key Manufacturers in Latin America
    • 10.5.3.Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4.Latin America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.5.5.Latin America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.5.6.Latin America Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.5.7.Brazil
      • 10.5.7.1.Overview
      • 10.5.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3.Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.7.4.Brazil Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.5.7.5.Brazil Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.5.8.Mexico
      • 10.5.8.1.Overview
      • 10.5.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3.Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.8.4.Mexico Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.5.8.5.Mexico Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.5.9.Argentina
      • 10.5.9.1.Overview
      • 10.5.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3.Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.9.4.Argentina Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.5.9.5.Argentina Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.5.10.Colombia
      • 10.5.10.1.Overview
      • 10.5.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3.Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.10.4.Colombia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.5.10.5.Colombia Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.5.11.Rest of LATAM
      • 10.5.11.1.Overview
      • 10.5.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3.Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.11.4.Rest of LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.5.11.5.Rest of LATAM Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
  • 10.6.Middle East and Africa
    • 10.6.1.Overview
    • 10.6.2.IVD IN CARDIOLOGY AND NEUROLOGY Key Manufacturers in Middle East and Africa
    • 10.6.3.Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4.Middle East and Africa Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.6.5.Middle East and Africa Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.6.6.Middle East and Africa Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.6.7.Saudi Arabia
      • 10.6.7.1.Overview
      • 10.6.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3.Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.7.4.Saudi Arabia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.6.7.5.Saudi Arabia Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.6.8.United Arab Emirates
      • 10.6.8.1.Overview
      • 10.6.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3.United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.8.4.United Arab Emirates Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.6.8.5.United Arab Emirates Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.6.9.Israel
      • 10.6.9.1.Overview
      • 10.6.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3.Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.9.4.Israel Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.6.9.5.Israel Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.6.10.Turkey
      • 10.6.10.1.Overview
      • 10.6.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3.Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.10.4.Turkey Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.6.10.5.Turkey Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.6.11.Algeria
      • 10.6.11.1.Overview
      • 10.6.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3.Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.11.4.Algeria Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.6.11.5.Algeria Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.6.12.Egypt
      • 10.6.12.1.Overview
      • 10.6.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3.Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.12.4.Egypt Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.6.12.5.Egypt Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.6.13.Rest of MEA
      • 10.6.13.1.Overview
      • 10.6.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3.Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.13.4.Rest of MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.6.13.5.Rest of MEA Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)

11.Key Vendor Analysis- IVD IN CARDIOLOGY AND NEUROLOGY Industry

  • 11.1.Competitive Dashboard
  • 11.2.Company Profiles
    • 11.2.1.Quest Diagnostics Incorporated
    • 11.2.2.BD
    • 11.2.3.Sysmex Corporation
    • 11.2.4.Siemens Healthineers AG
    • 11.2.5.Thermo Fisher Scientific Inc.
    • 11.2.6.Abbott
    • 11.2.7.F. Hoffmann-La Roche Ltd.
    • 11.2.8.Bio-Rad Laboratories, Inc.
    • 11.2.9.Beckman Coulter, Inc.
    • 11.2.10.Cardiol Therapeutics

12.360 Degree Analyst View

13.Appendix

  • 13.1.Research Methodology
  • 13.2.References
  • 13.3.Abbreviations
  • 13.4.Disclaimer
  • 13.5.Contact Us